FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns pharmaceutical composition of metered aerosols containing antiasthmatic agents in the form of suspensions, solutions and emulsions. The metered aerosols are characterised with improved pharmaceutical properties and high storage stability. The pharmaceutical composition of metered aerosols containing antiasthmatic agents in the form of suspensions, solutions and emulsions, contains therapeutically effective amounts of Salbutamol or its salts, or formoterol fumarate or budesonide or beclomehasone dipropionate, propellent R 134A and target additives including ethyl alcohol, glycerine, isopropyl myristate, Tween 80, water.
EFFECT: suitable for treatment of various obstructive pulmonary diseases such as bronchial asthma, bronchitis, pneumonia etc.
4 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHALATION FORMULATION IN FORM OF AEROSOL FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2504402C1 |
| CRYSTALLINE LEVOSALBUTAMOL SULFATE, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH CONTAINS IT | 2005 |
|
RU2440972C2 |
| AEROSOL PREPARATION OF IPRATROPIUM BROMIDE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2519653C1 |
| COMBINED AEROSOL PREPARATION FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2536253C1 |
| AEROSOL PREPARATION BASED ON FENOTEROL HYDROBROMIDE FOR TREATING RESPIRATORY DISEASES | 2015 |
|
RU2577289C1 |
| AEROSOL PHARMACEUTICAL COMPOSITION, A METHOD OF TREATMENT OF PATIENTS WITH RESPIRATORY DISEASES | 1992 |
|
RU2129424C1 |
| TROVENTOL-BASED COMPOSITION | 2006 |
|
RU2457832C2 |
| PHARMACEUTICAL AEROSOL COMPOSITION | 2009 |
|
RU2565438C2 |
| COMPRESSED AIR METERED-DOSE INHALER CONTAINING A BUFFERED PHARMACEUTICAL COMPOSITION | 2021 |
|
RU2795000C2 |
| MEASURED DOSE INHALER WITH COMPRESSED AIR SPRAYING, CONTAINING BUFFERED PHARMACEUTICAL COMPOSITION | 2021 |
|
RU2792689C2 |
